Strados now delivers the full spectrum of respiratory endpoints — cough monitoring, remote spirometry, FeNO, lung sound analysis, and eCOA — as a single specialist partner. Leveraging Strados' respiratory intelligence and incorporating the validated clinical trial capabilities of NuvoAir.
Peer-reviewed in
Respiratory Research
ERJ
CHEST
npj Digital Medicine
70+ peer-reviewed publications
Presented at ATS
ERS
DIA
Integrated Endpoint Suite
Next-generation, medical-grade technology designed to deliver the most accurate and patient-friendly respiratory monitoring available.
FDA Cleared · CE Mark
Air Next Spirometer
FDA 510(k) · CE Mark
RESP® Biosensor
Clinical Trial Ready
RESP® Watch
Point-of-Care
NObreath® FeNO
Software
eCOA
The Strados Intelligence Advantage
How Strados brings AI, proprietary biosensing, and human expertise together to produce regulatory-grade respiratory evidence in the real world.
Episodic clinic visits miss the disease burden that lives between appointments. Strados captures what matters — continuously in patients' daily lives — for every endpoint in the suite.
AI detects. Experts review. Audio is retained. The full evidence chain — from capture to annotation to audit — is preserved and accessible. This is what separates Strados from algorithm and human review-only solutions.
Every data point we deliver is traceable, defensible, and built for regulatory submission. Not just processed and reported — but reviewed, annotated, and audit-ready from the moment it is captured.
Trusted Globally
Trusted by leading pharma sponsors and respiratory CRO partners across Phase I–IV clinical trials in 34 countries.
"We needed a partner who could support our global cough endpoint study with the rigour our regulatory team required. Strados delivered."
— Clinical Operations Lead, Phase II ILD program
Built for Your Program
For Sponsors
Strados delivers every respiratory endpoint your program needs — cough monitoring, spirometry, FeNO, lung sound analysis, and eCOA — through a single specialist partner. One contract, one data stream, one point of accountability. Scientifically validated, GCP-compliant, and built for regulatory submission.
Design a StudyFor CROs
Strados is the single integration point for all respiratory endpoints in complex multi-modal programs. Complementary to — not competing with — your broader eClinical infrastructure. Phase I–IV delivery experience across 34 countries, with full site support, device logistics, and GCP-compliant data.
Explore CRO PartnershipWhy Strados
Patient and physician founded, dedicated to making every breath count. We're committed to improving quality of life for patients with respiratory diseases.
We built the world's first FDA-cleared device to continuously capture lung sounds. That breakthrough wasn't a one-time event — it reflects how we think. We are always ahead of where the science is going, not catching up to where it's been.
FDA 510(k) cleared devices, validated algorithms, retained audio, GCP-compliant processes, and expert overread at every step. Built for pivotal trials from day one — not adapted for them after the fact.
Capture what happens between clinic visits — the moments that matter most for understanding how patients actually respond to treatment. Ambulatory, continuous, and reflective of real disease burden.
Low-burden wearables and home-based assessments that fit into patients' daily lives. We measure what matters to patients — not just what's convenient to collect at a clinic visit.
Eliminate fragmented vendor relationships. Cough, spirometry, FeNO, lung sounds, and eCOA — one platform, one data stream, one specialist partner across every respiratory endpoint your program needs.
Our Collaborators
Stay Informed
Tell us about your program and we'll help you design the right respiratory endpoint strategy.
Design a Study
